Does CATEQUENTINIB Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with CATEQUENTINIB. This represents 1.9% of all adverse event reports for CATEQUENTINIB.
6
Reports of Interstitial lung disease with CATEQUENTINIB
1.9%
of all CATEQUENTINIB reports
3
Deaths
1
Hospitalizations
How Dangerous Is Interstitial lung disease From CATEQUENTINIB?
Of the 6 reports, 3 (50.0%) resulted in death, 1 (16.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CATEQUENTINIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CATEQUENTINIB Cause?
Myelosuppression (84)
Off label use (37)
Diarrhoea (33)
Hypertension (26)
Nausea (26)
Vomiting (26)
Rash (25)
Thrombocytopenia (24)
Fatigue (23)
Anaemia (22)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CATEQUENTINIB Alternatives Have Lower Interstitial lung disease Risk?
CATEQUENTINIB vs CC-4047
CATEQUENTINIB vs CEDAZURIDINE\DECITABINE
CATEQUENTINIB vs CEDIRANIB
CATEQUENTINIB vs CEFACLOR
CATEQUENTINIB vs CEFADROXIL